Moderna Officer Stephen Hoge Files Form 144 to Sell $8.64M in Stock

Executive Summary

On October 15, 2026, Stephen Hoge, an Officer of Moderna, Inc. (MRNA), filed a Form 144 notice proposing the sale of 39,145 shares of common stock through Fidelity Brokerage Services LLC. The estimated market value of the proposed transaction is $8,640,032.55, implying an average price per share of approximately $220.72.

Transaction & Acquisition Details

• Nature of Acquisition: The 39,145 shares are being acquired via a stock option exercise from the issuer on October 15, 2026, paid in cash.
• Trading Plan: The planned sale is executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 15, 2026.
• Prior 3-Month Activity:
  • 07/15/2026: 53,336 shares sold for $3,605,513.60
  • 09/14/2026: 40,294 shares sold for $5,807,747.48
  • 09/15/2026: 40,281 shares sold for $5,883,708.71
  • 10/14/2026: 39,224 shares sold for $8,373,519.16

Market Impact & Significance

This proposed sale represents routine option exercise-and-sell activity executed pursuant to a pre-scheduled Rule 10b5-1 plan. Because the transaction represents a minor percentage of Moderna's 399.2 million outstanding shares and follows a pre-established plan, market impact is anticipated to be low to moderate.